B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

TXNRD1

MOLECULAR TARGET

thioredoxin reductase 1

UniProt: AAC35244NCBI Gene: 5881921 compounds

TXNRD1 (thioredoxin reductase 1) is targeted by 21 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting TXNRD1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Azathioprine1.393
2Cisplatin1.102
3Dinitrochlorobenzene1.102
4Pueraria0.691
5myricetin-3-O-galactopyranoside [Supplementary Concept]0.691
6Vitamin0.691
7Anisomycin0.691
8Diiodotyrosine0.691
9Ethylmaleimide0.691
10Chlorophyll Binding Proteins0.691
11hydroxyindoleacetic acid0.691
12Idazoxan0.691
13Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on0.691
14Levodopa0.691
15Methyldopa0.691
16Methysergide0.691
17Nitrofurazone0.691
18Oxyphenbutazone0.691
19Oxytetracycline0.691
20Promethazine0.691
21tyrphostin 90.691

About TXNRD1 as a Drug Target

TXNRD1 (thioredoxin reductase 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 21 compounds with documented TXNRD1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

TXNRD1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.